251. MDR/XDR-TB management of patients and contacts
- Author
-
Marina Tadolini, Fabrizio Palmieri, Katerina Manika, Edvardas Danila, H. Mustafa Hamdan, Heinke Kunst, Sergey Borisov, Christian Wejse, J.J. Cebrian Gallardo, Alex Filippov, Vinicio Manfrin, Tom H. M. Ottenhoff, Domingo Palmero, Onno W. Akkerman, M. Nieto Marcos, Emanuele Pontali, R. Gomez Rosso, Zarir F Udwadia, Anna Cristina Calçada Carvalho, Cecile Magis-Escurra, M. Pretti Dalcolmo, Eskild Petersen, J. Cadiñanos Loidi, Norbert Ndjeka, Jeremiah Chakaya, L. Davies Forsman, Fernanda Carvalho de Queiroz Mello, Selene Manga, T. Abu Arkub, Giovanni Sotgiu, Alberto Matteelli, Jose Figueroa, Ben J. Marais, Askar Yedilbayev, Gabriella Ferlazzo, Riccardo Alagna, Judith Bruchfeld, Liga Kuksa, Susanna Esposito, Raquel Duarte, Antonio Spanevello, Justin T Denholm, Jose A. Caminero, B. Formenti, M. van den Boom, Alena Aleksa, Dina Visca, C. Torres, L. Mendoza, Evgeny Belilovski, S. Koirala, A. Mesi, Ivan Solovic, Martin Enwerem, Rosella Centis, Keertan Dheda, H. Simon Schaaf, Alimuddin Zumla, N. Escobar Salinas, A.P. Santos, Alena Skrahina, Apostolos Papavasileiou, Alberto Piubello, Jesica Mazza-Stalder, Lia D'Ambrosio, Agostina Pontarelli, Enrique Bernal, Giovanni Battista Migliori, Roland Diel, Barbara Seaworth, Alberto L. García-Basteiro, Petros Isaakidis, S. Quirós Fernandez, Jean-Pierre Zellweger, Grigory V. Volchenkov, D. Rossato Silva, R. Zaleskis, Martin J. Boeree, Simon Tiberi, Skaidrius Miliauskas, J.M. García García, Saulius Diktanas, Gina Gualano, Claudia C. Dobler, Daniela Maria Cirillo, Jan-Willem C. Alffenaar, Adrian Rendon, Valentina Marchese, Yang Li, R. Romero, Andrey Maryandyshev, Marie-Christine Payen, M. Sinitsyn, Delia Goletti, E. Martínez Robles, Anna Kaluzhenina, Alessandro Wasum Mariani, Marcela Muñoz Torrico, F-X. Blanc, Charalampos, Instituto de Saúde Pública da Universidade do Porto, Microbes in Health and Disease (MHD), and Academic Medical Center
- Subjects
0301 basic medicine ,medicine.medical_treatment ,Extensively Drug-Resistant Tuberculosis ,PROPHYLAXIS ,0302 clinical medicine ,Diagnòstic ,Risk Factors ,Epidemiology ,Tuberculosis, Multidrug-Resistant ,Diagnosis ,IMIPENEM/CLAVULANATE ,Medicine ,Infection control ,030212 general & internal medicine ,Child ,Functional evaluation ,PYRAZINAMIDE ,Rehabilitation ,General Medicine ,Multidrug-Resistant ,Infectious Diseases ,Child, Preschool ,SAFETY ,Practice Guidelines as Topic ,MDR-TB ,Prevention ,Rehabilitation of sequelae ,Treatment ,XDR-TB ,Medical emergency ,Microbiology (medical) ,Adult ,medicine.medical_specialty ,Tuberculosis ,Tuberculosi ,TRANSMISSION ,030106 microbiology ,REGIMENS ,lcsh:Infectious and parasitic diseases ,LATENT TUBERCULOSIS ,03 medical and health sciences ,Humans ,lcsh:RC109-216 ,MULTIDRUG-RESISTANT TUBERCULOSIS ,Preschool ,Infection Control ,business.industry ,Continuous flow ,Public health ,CHILD CONTACTS ,medicine.disease ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,Contact Tracing ,Latent Tuberculosis ,business ,Contact tracing - Abstract
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabilitation requires frequent update of existing guidelines. This review is aimed at providing clinicians and public health staff with an updated and easy-to-consult document arising from consensus of Global Tuberculosis Network (GTN) experts. The core published documents and guidelines have been reviewed including the recently published MDR-TB WHO rapid advice and ATS/CDC/ERS/IDSA guidelines. After a rapid review of epidemiology and risk factors, the clinical priorities on MDR-TB diagnosis (including whole genome sequencing and drug-susceptibility testing interpretations) and treatment (treatment design and management, TB in children) are discussed. Furthermore, the review comprehensively describes the latest information on contact tracing and LTBI management in MDR-TB contacts, while providing guidance on post-treatment functional evaluation and rehabilitation of TB sequelae, infection control and other public health priorities.
- Published
- 2020
- Full Text
- View/download PDF